<DOC>
	<DOCNO>NCT02223117</DOCNO>
	<brief_summary>This `` first-in-human '' exploratory IND , single-center study ass safety , toxicity , hematology , immunogenicity sub-therapeutic `` microdoses '' autologous Thrombosomes® healthy human subject .</brief_summary>
	<brief_title>Evaluation Safety Immunogenicity Autologous Thrombosomes® Healthy Human Subjects ; A Microdose Escalation Study ( Cohorts 1 - 4 ) Repeat Microdose Immunogenicity Study ( Cohort 5 )</brief_title>
	<detailed_description />
	<criteria>1 . Minimum weight 110 pound ( 50 kg ) 2 . Age 1845 year 3 . Able willing provide inform consent 4 . Has permanent address phone/email contact notification , able come research site schedule study visit 60 day last study infusion 5 . Understands , speak read standard English language 6 . Normal healthy subject able pas universal blood donor history questionnaire screen 1 . Breastfeeding female 2 . At time , previously pregnant female 3 . Participation experimental drug/device study within past 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>